Sophia Genetics SA:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Sophia Genetics SA - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10438
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sophia Genetics SA (Sophia Genetics) is a health tech company that provides technological solutions such as SOPHiA Artificial Intelligence for clinical genomics and next generation sequencing (NGS) data analysis. The company also provides dry lab, bundle solution, and integrated diagnostic solutions. It offers SOPHiA, a technology that detects, annotates and pre-classifies genomic variants; and SOPHiA DDM, a software-as-a-service platform for routine diagnostic testing. The company facilitates the quick adoption of genomic testing globally, converting data into actionable clinical insights, Its technologies find application in fields such as cardiology, metabolism, pediatrics and hereditary cancers. The company serves clinicians, hospitals and other healthcare institutions. It has a presence in Switzerland and France. Sophia Genetics is headquartered in Saint Sulpice, Switzerland.

Sophia Genetics SA – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sophia Genetics SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sophia Genetics SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Sophia Genetics SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sophia Genetics SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Sophia Genetics SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Sophia Genetics SA, Medical Equipment, Deal Details 10
Venture Financing 10
Sophia Genetics Raises USD30 Million in Series D Financing 10
Sophia Genetics Raises USD15 Million in Series C Financing 11
Sophia Genetics Raises USD13.8 Million in Series B Venture Financing 12
Sophia Genetics Raises USD3 Million in Series A Venture Financing 13
Sophia Genetics Raises USD1 Million in Seed Financing 14
Partnerships 15
Sophia Genetics Enters into Agreement with Horizon Discovery Group 15
Sophia Genetics Enters into Agreement with Qiagen 16
Sophia Genetics Enters into Agreement with ArcherDx 17
Genohm Enters into Agreement with Interactive Biosoftware 18
Sophia Genetics Enters into Co-Marketing Agreement with Illumina 19
Sophia Genetics Enters into Agreement with Multiplicom 20
Sophia Genetics Enters into Agreement with Integrated DNA 21
Sophia Genetics Enters into Agreement with Swift Biosciences 22
Sophia Genetics SA – Key Competitors 23
Sophia Genetics SA – Key Employees 24
Sophia Genetics SA – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Strategy And Business Planning 26
Sep 24, 2018: SOPHiA GENETICS Sets up Headquarters in Boston to Meet Growing Demand in the U.S. 26
Corporate Communications 27
Jan 11, 2018: SOPHiA GENETICS appoints Valentin Matillon as new Chief Financial Officer 27
Jun 28, 2017: Sophia Genetics Ranked 30th in MIT Technology Review 2017 List of ‘50 Smartest Companies’ 28
Product News 29
Jun 06, 2017: Sophia Artificial Intelligence Empowers Liquid Biopsies To Fight Cancer 29
May 29, 2017: SOPHiA AI Unlocks the Power of Exome Sequencing for Clinical Diagnostics 30
Mar 24, 2017: African Hospitals Adopt Sophia Artificial Intelligence To Trigger Continent-Wide Healthcare Leapfrogging Movement 32
Mar 09, 2017: Sophia Genetics Set To Break Through The Strategic Threshold Of 100K Patients’ Genomic Profiles Analyzed By Its Artificial Intelligence Sophia 33
Other Significant Developments 35
Jan 24, 2018: IA Sophia Integrates Radiology Expertise Of French Mathematician Thierry Colin 35
Oct 11, 2017: Mexico Embraces the Clinical Genomics Movement with Six Institutions Now Using Sophia AI 36
Feb 13, 2017: Sophia AI Becomes the Technology of Choice for Clinical Diagnostic in Latin America 38
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Sophia Genetics SA, Medical Equipment, Key Facts 2
Sophia Genetics SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Sophia Genetics SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sophia Genetics SA, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Sophia Genetics SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sophia Genetics SA, Deals By Market, 2012 to YTD 2018 8
Sophia Genetics SA, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Sophia Genetics Raises USD30 Million in Series D Financing 10
Sophia Genetics Raises USD15 Million in Series C Financing 11
Sophia Genetics Raises USD13.8 Million in Series B Venture Financing 12
Sophia Genetics Raises USD3 Million in Series A Venture Financing 13
Sophia Genetics Raises USD1 Million in Seed Financing 14
Sophia Genetics Enters into Agreement with Horizon Discovery Group 15
Sophia Genetics Enters into Agreement with Qiagen 16
Sophia Genetics Enters into Agreement with ArcherDx 17
Genohm Enters into Agreement with Interactive Biosoftware 18
Sophia Genetics Enters into Co-Marketing Agreement with Illumina 19
Sophia Genetics Enters into Agreement with Multiplicom 20
Sophia Genetics Enters into Agreement with Integrated DNA 21
Sophia Genetics Enters into Agreement with Swift Biosciences 22
Sophia Genetics SA, Key Competitors 23
Sophia Genetics SA, Key Employees 24
Sophia Genetics SA, Subsidiaries 25

List of Figures
Sophia Genetics SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Sophia Genetics SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Sophia Genetics SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Sophia Genetics SA, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Sophia Genetics SA, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sophia Genetics SA, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Sophia Genetics SA, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sophia Genetics SA, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Sophia Genetics SA:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Canadian Pacific Railway Limited (CP):企業の財務・戦略的SWOT分析
    Canadian Pacific Railway Limited (CP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • CIMIC Group Ltd (CIM):企業の財務・戦略的SWOT分析
    CIMIC Group Ltd (CIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Trammo Inc.:戦略・SWOT・企業財務分析
    Trammo Inc. - Strategy, SWOT and Corporate Finance Report Summary Trammo Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Check Point Software Technologies Ltd (CHKP):企業の財務・戦略的SWOT分析
    Check Point Software Technologies Ltd (CHKP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • RegeneRx Biopharmaceuticals Inc (RGRX):企業の財務・戦略的SWOT分析
    Summary RegeneRx Biopharmaceuticals Inc (RegeneRx) is a clinical-stage biopharmaceutical company that designs, researches and develops novel peptides targeted at diseases with unmet medical needs. The company offers clinical trials, science and discovery and business development services. Its busine …
  • Axelar AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Axelar AB (Axelar) is a drug development company that develops various novel anti-cancer treatments. The company lead drug candidateAXL1717 is used for the treatmentof non-small cell lung cancer. It also offers treatments for disease such as glioblastoma, sarcoma, malignant melanoma and mult …
  • Vietnam Export Import Commercial Joint Stock Bank
    Vietnam Export Import Commercial Joint Stock Bank - Strategy, SWOT and Corporate Finance Report Summary Vietnam Export Import Commercial Joint Stock Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structur …
  • 3M India Limited (3MINDIA):企業の財務・戦略的SWOT分析
    3M India Limited (3MINDIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Cantargia AB (CANTA):企業の財務・戦略的SWOT分析
    Summary Cantargia AB (Cantargia), a subsidiary of Lund University Bioscience AB is a biotechnology company that develops antibody based cancer treatments. The company’s product candidate CAN04 is used for the treatment of several cancers including non-small cell lung cancer and pancreatic cancer. It …
  • Murata Manufacturing Co Ltd (6981):企業の財務・戦略的SWOT分析
    Murata Manufacturing Co Ltd (6981) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Ascendis Pharma A/S (ASND):企業の財務・戦略的SWOT分析
    Summary Ascendis Pharma A/S (Ascendis) is a biopharmaceutical company that offers drug discovery and development services. The company’s pipeline products include transcon growth hormone, transcon PTH, transcon CNP, and transcon peptides. Ascendis conducts research and develops new drug candidates f …
  • Strat Aero Plc (AERO):企業の財務・戦略的SWOT分析
    Summary Strat Aero Plc (Strat Aero) formally known as Remote Monitored Systems PLC is an aerospace company that offers management systems, training solutions and consultancy services to the Unmanned Aerial Vehicle (UAV) sector. The company’s services include survey and inspection services, surveilla …
  • Porto Seguro SA:企業の戦略・SWOT・財務情報
    Porto Seguro SA - Strategy, SWOT and Corporate Finance Report Summary Porto Seguro SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Eastman Chemical Company:企業のM&A・事業提携・投資動向
    Eastman Chemical Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eastman Chemical Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Main Line Health System:企業の戦略的SWOT分析
    Main Line Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Syndax Pharmaceuticals Inc (SNDX):企業の財務・戦略的SWOT分析
    Summary Syndax Pharmaceuticals Inc (Syndax) is a biopharmaceutical company that develops and commercializes therapies for multiple cancer indications. The company’s lead product candidate includes entinostat, an oral, small molecule drug candidate, which is in phase 3 clinical trial used for the tre …
  • Esco Technologies Inc (ESE):企業の財務・戦略的SWOT分析
    Esco Technologies Inc (ESE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • SoftBank Group Corp (9984):電力:M&Aディール及び事業提携情報
    Summary SoftBank Group Corp (SoftBank) is a provider of integrated telecommunications services. The company is involved in various businesses related to the information industry with presence in fixed-line telecommunications, mobile communications, internet services, and distribution. It offers serv …
  • Quark Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Quark Pharmaceuticals Inc (Quark), a subsidiary of SBI Biotech Co Ltd, is a clinical-stage pharmaceutical company in the development of novel RNAi-based therapeutics. It offers under development products which include PF-655, a synthetic siRNA which is used for the treatment of diabetic macu …
  • Matrai Eromu ZRt:企業の戦略的SWOT分析
    Matrai Eromu ZRt - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆